# LETAIRIS
> **NDA022081** · New Drug Application · Sponsor: GILEAD · Approved 2007-06-15
## Drug
- **FDA Application Number:** NDA022081
- **Application type:** New Drug Application
- **Brand name:** LETAIRIS
- **Generic name:** AMBRISENTAN
- **Active ingredients:** AMBRISENTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2007-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022081)
---
*AI Analytics · CC0 1.0*